1FX — Ananda Pharma Balance Sheet
0.000.00%
- €2.15m
- €2.36m
- £0.00m
Annual balance sheet for Ananda Pharma, fiscal year end - January 31st, GBP millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | — | — | 0.019 | 0.084 | 1.66 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.004 | 0.087 | 0.18 | 0.05 | 0.156 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.013 | 0.111 | 0.276 | 0.162 | 1.82 |
| Net Property, Plant And Equipment | — | — | 1.76 | 1.57 | 1.36 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 1.29 | 2.36 | 6.51 | 3.6 | 4.63 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.462 | 1.49 | 4.51 | 3.2 | 2.45 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Liabilities | 0.462 | 2.08 | 5.3 | 3.25 | 2.5 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 0.831 | 0.288 | 1.2 | 0.351 | 2.13 |
| Total Liabilities & Shareholders' Equity | 1.29 | 2.36 | 6.51 | 3.6 | 4.63 |
| Total Common Shares Outstanding |